Page last updated: 2024-08-21

oleanolic acid and Leukemia, Erythroblastic, Acute

oleanolic acid has been researched along with Leukemia, Erythroblastic, Acute in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cerio, AM; Labbaye, C; Mariani, G; Pelosi, E; Petronelli, A; Santoro, S; Saulle, E; Testa, U	1

Other Studies

1 other study(ies) available for oleanolic acid and Leukemia, Erythroblastic, Acute

Article	Year
CDDO-Im is a stimulator of megakaryocytic differentiation. Leukemia research, 2011, Volume: 35, Issue:4 Topics: Antigens, CD34; Apoptosis; Blotting, Western; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Erythroid Cells; Flow Cytometry; GATA1 Transcription Factor; GATA2 Transcription Factor; Granulocytes; Hematopoietic Stem Cells; Humans; Imidazoles; Integrin beta3; Leukemia, Erythroblastic, Acute; Megakaryocytes; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Monocytes; Oleanolic Acid; Platelet Membrane Glycoprotein IIb; Time Factors	2011

Article

Year

CDDO-Im is a stimulator of megakaryocytic differentiation.

Leukemia research, 2011, Volume: 35, Issue:4

Topics: Antigens, CD34; Apoptosis; Blotting, Western; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Erythroid Cells; Flow Cytometry; GATA1 Transcription Factor; GATA2 Transcription Factor; Granulocytes; Hematopoietic Stem Cells; Humans; Imidazoles; Integrin beta3; Leukemia, Erythroblastic, Acute; Megakaryocytes; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Monocytes; Oleanolic Acid; Platelet Membrane Glycoprotein IIb; Time Factors

2011